Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.6.0.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents [note 5] $ 15,233 $ 34,310
Short-term investments [note 5] 10,230 20,876
Interest receivable 32 111
Amounts receivable 478 14
Prepaid expenses 954 1,987
Total current assets 26,927 57,298
Restricted cash [note 5] 272 272
Property and equipment, net [note 6] 258 602
Other assets [note 8] 13 37
Total assets 27,470 58,209
Current liabilities:    
Accounts payable 2,121 1,343
Accrued liabilities other 2,442 641
Accrued clinical liabilities 3,415 9,966
Accrued compensation 188 1,267
Current portion of long-term obligations [note 12] 57 52
Lease termination liability [note 7]   1,250
Deferred collaboration revenue [note 4]   5,040
Warrant liability [note 5 and note 10] 232 1,105
Total current liabilities 8,455 20,664
Long-term obligations, less current portion [note 12] 49 105
Total liabilities 8,504 20,769
Commitments and contingencies [note 4 and note 12]
Stockholders' equity:    
Common stock, $0.001 par value, 75,000,000 shares authorized, 30,059,514 and 29,846,991 issued at December 31, 2016 and December 31, 2015, respectively, and 30,025,521 and 29,812,998 outstanding at December 31, 2016 and December 31, 2015, respectively 29 29
Additional paid-in capital 213,239 211,590
Accumulated deficit (196,942) (176,811)
Accumulated other comprehensive income 2,640 2,632
Total stockholders' equity 18,966 37,440
Total liabilities and stockholders' equity $ 27,470 $ 58,209